Amarin (AMRN)
(Delayed Data from NSDQ)
$0.59 USD
-0.01 (-1.42%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.59 0.00 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Brokerage Reports
0 items in cart
Amarin Corporation PLC [AMRN]
Reports for Purchase
Showing records 261 - 280 ( 367 total )
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Watching Scripts and Waiting on Q1 Sales Data for Early Read on Vascepa Launch; Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Expect Focus on Vascepa Launch and ANCHOR sNDA Filing During Upcoming Earnings Call; Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Vascepa Patent Update; Focus on Upcoming Commercial Launch;
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Shifting Focus to Upcoming Self-Commercialization as NCE is Delayed Again; Reiterate NEUTRAL and Lowering FV to $10 from $15
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of December 16
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Fifth Time''s a Charm?; What''s at Stake Entering NCE Week; Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Sales Force Hiring and $100MM Financing; ''520 (ANCHOR) Allowance a Consolation for Investors; Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Vascepa Patent Tracker: ''247 (MARINE Family) Notice of Allowance.
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Vascepa Patent Tracker - ''775 NOA; Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of November
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Moving Forward with Commercialization and Hopeful that NCE Clarity Brings Strategic Deal; Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
NCE and M&A: Potential Implications; Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.